Literature DB >> 34136949

Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.

Stinne Tranekær1, Dennis Lund Hansen2,3, Bart J Biemond4, Anne Lykke Sørensen1, Andreas Glenthøj5, Jesper Petersen5, Henrik Frederiksen1,6.   

Abstract

Priapism is a persistent, painful erection, which can lead to permanent penile damage and reduced quality of life. Patients with sickle cell disease have an increased risk of priapism which has been related to chronic hemolysis. This study investigates the prevalence of priapism in all major hereditary and acquired forms of hemolytic disorders. Patients with hemolytic disorders were identified in the nationwide Danish Hemolysis Cohort. Each patient was age-sex-matched with 50 comparisons from the general population without hemolysis. We identified the episodes of hospital-registered priapism events for both patients with hemolysis disorders and comparisons in the Danish National Patient Register between 1977 and 2016. We identified 4181 male patients with hemolytic disorders and 205,994 male comparisons, with 2,294,027 person-years of total observation time. Totally, 101 episodes of priapism occurred during follow-up period. Six episodes of priapism were recorded in three patients with a hemolytic disorder, all affected by sickle cell disease. Two of these patients had verified genotype HbSS. The incidence rate for first priapism in sickle cell disease was 432.8 per 100,000 person-years [95% CI: 139.6; 1341.8] versus 0.84 per 100,000 person-years [95% CI 0.54; 1.32] in comparisons. Using a large nationwide cohort, we found that only sickle cell disease is associated with priapism among patients with hemolytic disorders. The incidence rate of priapism in patients with sickle cell disease was lower than previously reported.

Entities:  

Keywords:  Hemolysis; Hemolytic disorders; Priapism; Sickle cell disease

Year:  2021        PMID: 34136949     DOI: 10.1007/s00277-021-04577-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  25 in total

1.  Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study.

Authors:  A B Adeyoju; A B K Olujohungbe; J Morris; A Yardumian; D Bareford; A Akenova; O Akinyanju; K Cinkotai; P H O'Reilly
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

Review 2.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

Review 3.  How I manage priapism due to sickle cell disease.

Authors:  Ade Olujohungbe; Arthur L Burnett
Journal:  Br J Haematol       Date:  2013-01-07       Impact factor: 6.998

Review 4.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

5.  Incidence of priapism in the general population.

Authors:  I A Eland; J van der Lei; B H Stricker; M J Sturkenboom
Journal:  Urology       Date:  2001-05       Impact factor: 2.649

6.  Hemolysis-associated priapism in sickle cell disease.

Authors:  Vikki G Nolan; Diego F Wyszynski; Lindsay A Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

Review 7.  Priapism.

Authors:  A Melman; S Serels
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

Review 8.  Medical and surgical management of priapism.

Authors:  J Cherian; A R Rao; A Thwaini; F Kapasi; I S Shergill; R Samman
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

Review 9.  Clinical Management of Priapism: A Review.

Authors:  Kazuyoshi Shigehara; Mikio Namiki
Journal:  World J Mens Health       Date:  2016-04-30       Impact factor: 5.400

10.  Priapism as the initial sign in hematologic disease: Case report and literature review.

Authors:  Luis Cuitláhuac Becerra-Pedraza; Luis Enrique Jiménez-Martínez; Iran Peña-Morfin; Rogelio Nava-Esquivel; Juan Alfredo Villegas-Martínez
Journal:  Int J Surg Case Rep       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.